Out-going Fisher & Paykel Healthcare director Geraldine McBride told shareholders at the listed medical device company’s virtual annual meeting that she felt the stock “was undervalued”.
The company’s share price has been on a downhill slide from a high of $35 to just over $20 in
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
